Australia markets closed
  • ALL ORDS

    7,306.00
    -38.20 (-0.52%)
     
  • AUD/USD

    0.7754
    +0.0005 (+0.07%)
     
  • ASX 200

    7,061.70
    -34.10 (-0.48%)
     
  • OIL

    65.31
    -0.32 (-0.49%)
     
  • GOLD

    1,793.00
    +8.70 (+0.49%)
     
  • BTC-AUD

    73,900.06
    +1,981.95 (+2.76%)
     
  • CMC Crypto 200

    1,465.96
    +60.65 (+4.32%)
     

Global Tissue Engineering Market to Reach $26.8 Billion by 2027

ReportLinker
·10-min read

Abstract: - Global Tissue Engineering Market to Reach $26. 8 Billion by 2027. - Amid the COVID-19 crisis, the global market for Tissue Engineering estimated at US$11 Billion in the year 2020, is projected to reach a revised size of US$26.

New York, April 21, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Tissue Engineering Industry" - https://www.reportlinker.com/p06033135/?utm_source=GNW
8 Billion by 2027, growing at a CAGR of 13.5% over the analysis period 2020-2027. Orthopedics, Musculoskeletal & Spine, one of the segments analyzed in the report, is projected to record a 12.1% CAGR and reach US$6.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Cardiology & Vascular segment is readjusted to a revised 15.7% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 13.1% CAGR
- The Tissue Engineering market in the U.S. is estimated at US$3.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.7 Billion by the year 2027 trailing a CAGR of 13.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.7% and 11.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10% CAGR.
- Cord Blood & Cell Banking Segment to Record 14.7% CAGR
- In the global Cord Blood & Cell Banking segment, USA, Canada, Japan, China and Europe will drive the 14.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.5 Billion in the year 2020 will reach a projected size of US$4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.2 Billion by the year 2027.

- Select Competitors (Total 33 Featured) -

  • Acelity L.P. Inc.

  • Advanced Cell Technology

  • Allergan Plc

  • Arteriocyte

  • Athersys

  • Baxter International Inc

  • BioMimetic Therapeutics

  • Cook Biotech Inc.

  • CryoLife

  • DePuy Synthes (Johnson & Johnson Services, Inc.)

  • Integra Life Sciences Corporation

  • LifeCell Kinetic Concepts

  • Medtronic

  • Organogenesis Inc.

  • RTI surgical

  • Sanofi

  • StemCells, Inc.

  • Stryker Corporation

  • Zimmer Biomet




Read the full report: https://www.reportlinker.com/p06033135/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Tissue Engineering
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 2: World 7-Year Perspective for Tissue Engineering by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2020 & 2027

Table 3: World Current & Future Analysis for Orthopedics,
Musculoskeletal & Spine by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 4: World 7-Year Perspective for Orthopedics,
Musculoskeletal & Spine by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2020 & 2027

Table 5: World Current & Future Analysis for Cardiology &
Vascular by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 6: World 7-Year Perspective for Cardiology & Vascular by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 7: World Current & Future Analysis for Cord Blood & Cell
Banking by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 8: World 7-Year Perspective for Cord Blood & Cell Banking
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

Table 9: World Current & Future Analysis for Cancer by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 10: World 7-Year Perspective for Cancer by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2020 & 2027

Table 11: World Current & Future Analysis for Gastrointestinal &
Gynecology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 12: World 7-Year Perspective for Gastrointestinal &
Gynecology by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2020 & 2027

Table 13: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 14: World 7-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 15: USA Current & Future Analysis for Tissue Engineering
by Application - Orthopedics, Musculoskeletal & Spine,
Cardiology & Vascular, Cord Blood & Cell Banking, Cancer,
Gastrointestinal & Gynecology and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 16: USA 7-Year Perspective for Tissue Engineering by
Application - Percentage Breakdown of Value Sales for
Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular,
Cord Blood & Cell Banking, Cancer, Gastrointestinal &
Gynecology and Other Applications for the Years 2020 & 2027

CANADA
Table 17: Canada Current & Future Analysis for Tissue
Engineering by Application - Orthopedics, Musculoskeletal &
Spine, Cardiology & Vascular, Cord Blood & Cell Banking,
Cancer, Gastrointestinal & Gynecology and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 18: Canada 7-Year Perspective for Tissue Engineering by
Application - Percentage Breakdown of Value Sales for
Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular,
Cord Blood & Cell Banking, Cancer, Gastrointestinal &
Gynecology and Other Applications for the Years 2020 & 2027

JAPAN
Table 19: Japan Current & Future Analysis for Tissue
Engineering by Application - Orthopedics, Musculoskeletal &
Spine, Cardiology & Vascular, Cord Blood & Cell Banking,
Cancer, Gastrointestinal & Gynecology and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 20: Japan 7-Year Perspective for Tissue Engineering by
Application - Percentage Breakdown of Value Sales for
Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular,
Cord Blood & Cell Banking, Cancer, Gastrointestinal &
Gynecology and Other Applications for the Years 2020 & 2027

CHINA
Table 21: China Current & Future Analysis for Tissue
Engineering by Application - Orthopedics, Musculoskeletal &
Spine, Cardiology & Vascular, Cord Blood & Cell Banking,
Cancer, Gastrointestinal & Gynecology and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 22: China 7-Year Perspective for Tissue Engineering by
Application - Percentage Breakdown of Value Sales for
Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular,
Cord Blood & Cell Banking, Cancer, Gastrointestinal &
Gynecology and Other Applications for the Years 2020 & 2027

EUROPE
Table 23: Europe Current & Future Analysis for Tissue
Engineering by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 24: Europe 7-Year Perspective for Tissue Engineering by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2020 & 2027

Table 25: Europe Current & Future Analysis for Tissue
Engineering by Application - Orthopedics, Musculoskeletal &
Spine, Cardiology & Vascular, Cord Blood & Cell Banking,
Cancer, Gastrointestinal & Gynecology and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 26: Europe 7-Year Perspective for Tissue Engineering by
Application - Percentage Breakdown of Value Sales for
Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular,
Cord Blood & Cell Banking, Cancer, Gastrointestinal &
Gynecology and Other Applications for the Years 2020 & 2027

FRANCE
Table 27: France Current & Future Analysis for Tissue
Engineering by Application - Orthopedics, Musculoskeletal &
Spine, Cardiology & Vascular, Cord Blood & Cell Banking,
Cancer, Gastrointestinal & Gynecology and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 28: France 7-Year Perspective for Tissue Engineering by
Application - Percentage Breakdown of Value Sales for
Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular,
Cord Blood & Cell Banking, Cancer, Gastrointestinal &
Gynecology and Other Applications for the Years 2020 & 2027

GERMANY
Table 29: Germany Current & Future Analysis for Tissue
Engineering by Application - Orthopedics, Musculoskeletal &
Spine, Cardiology & Vascular, Cord Blood & Cell Banking,
Cancer, Gastrointestinal & Gynecology and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 30: Germany 7-Year Perspective for Tissue Engineering by
Application - Percentage Breakdown of Value Sales for
Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular,
Cord Blood & Cell Banking, Cancer, Gastrointestinal &
Gynecology and Other Applications for the Years 2020 & 2027

ITALY
Table 31: Italy Current & Future Analysis for Tissue
Engineering by Application - Orthopedics, Musculoskeletal &
Spine, Cardiology & Vascular, Cord Blood & Cell Banking,
Cancer, Gastrointestinal & Gynecology and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 32: Italy 7-Year Perspective for Tissue Engineering by
Application - Percentage Breakdown of Value Sales for
Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular,
Cord Blood & Cell Banking, Cancer, Gastrointestinal &
Gynecology and Other Applications for the Years 2020 & 2027

UNITED KINGDOM
Table 33: UK Current & Future Analysis for Tissue Engineering
by Application - Orthopedics, Musculoskeletal & Spine,
Cardiology & Vascular, Cord Blood & Cell Banking, Cancer,
Gastrointestinal & Gynecology and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 34: UK 7-Year Perspective for Tissue Engineering by
Application - Percentage Breakdown of Value Sales for
Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular,
Cord Blood & Cell Banking, Cancer, Gastrointestinal &
Gynecology and Other Applications for the Years 2020 & 2027

REST OF EUROPE
Table 35: Rest of Europe Current & Future Analysis for Tissue
Engineering by Application - Orthopedics, Musculoskeletal &
Spine, Cardiology & Vascular, Cord Blood & Cell Banking,
Cancer, Gastrointestinal & Gynecology and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 36: Rest of Europe 7-Year Perspective for Tissue
Engineering by Application - Percentage Breakdown of Value
Sales for Orthopedics, Musculoskeletal & Spine, Cardiology &
Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal &
Gynecology and Other Applications for the Years 2020 & 2027

ASIA-PACIFIC
Table 37: Asia-Pacific Current & Future Analysis for Tissue
Engineering by Application - Orthopedics, Musculoskeletal &
Spine, Cardiology & Vascular, Cord Blood & Cell Banking,
Cancer, Gastrointestinal & Gynecology and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 38: Asia-Pacific 7-Year Perspective for Tissue
Engineering by Application - Percentage Breakdown of Value
Sales for Orthopedics, Musculoskeletal & Spine, Cardiology &
Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal &
Gynecology and Other Applications for the Years 2020 & 2027

REST OF WORLD
Table 39: Rest of World Current & Future Analysis for Tissue
Engineering by Application - Orthopedics, Musculoskeletal &
Spine, Cardiology & Vascular, Cord Blood & Cell Banking,
Cancer, Gastrointestinal & Gynecology and Other Applications -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 40: Rest of World 7-Year Perspective for Tissue
Engineering by Application - Percentage Breakdown of Value
Sales for Orthopedics, Musculoskeletal & Spine, Cardiology &
Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal &
Gynecology and Other Applications for the Years 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 33
Read the full report: https://www.reportlinker.com/p06033135/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001